一种基于黄素的HDACs抑制剂,用于乳腺癌的向声动力疗法
Xing Lu1, Ziwei Wang2, Yu Zhang1
1Key laboratory of Plant Resource Conservation and Germplasm Innovation in Mountainous Region (Ministry of Education), Guizhou Engineering Laboratory for Synthetic Drugs, School of Pharmaceutical Sciences, Guizhou University, Guiyang 550025, PR China.
International journal of biological macromolecules
|December 13, 2024
概括
一种新型药物CURSAHA通过抑制组织激素脱乙酶 (HDACs) 和利用声动疗法来向癌症. 它在临床前模型中显示出强大的抗瘤作用,为癌症治疗提供了一个有希望的新途径.
科学领域:
- 药用化学 医学化学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 基因组脱乙酶 (HDACs) 是癌症治疗中的关键标.
- 开发具有多种治疗机制的新药对于有效的癌症治疗至关重要.
研究的目的:
- 设计和合成CURSAHA,这是一个多功能剂,结合了Vorinostat和黄素的药物.
- 评估CURSAHA对癌细胞的HDAC抑制和声动力学治疗潜力.
主要方法:
- 沃里诺斯塔特和黄素的药融合形成了CURSAHA.
- 评估广泛的HDAC抑制活性.
- 通过在超声波下通过ROS生成来研究声动力学活性.
- 在体外和体外模型中评估抗瘤疗效.
主要成果:
- CURSAHA有效地抑制了广泛的HDACs,抑制了HDACs过度表达的癌细胞.
- 在超声波下,CURSAHA通过产生反应性氧物种 (ROS) 来表现出声动疗活性.
- 由CURSAHA产生的ROS通过氧化还原反应促进HDAC的下调.
- 在体外和体内癌症模型中,CURSAHA显示出显著的抗瘤活性.
结论:
- 库尔萨哈是一种强大的多功能抗癌剂,具有双重HDAC抑制和声动疗能力.
- 该剂通过ROS介导的氧化还原反应来降低HDACs的能力是关键机制.
- 作为癌症治疗进一步发展的候选人,CURSAHA显示出相当大的前景.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


